The results showed potentially anti-osteosarcoma properties, which appear to be at least partially attributable to the inhibition of Akt and AP-1 signal pathways in human and mouse osteosarcoma cancer cell lines (Saos-2, MNNG/HOS, 143B and LM8). The gene discussed is AKT1; the disease is osteosarcoma.